Evidence map›Paper›PMID 20722419›Full record

ArticleBiochemistry2010

Contribution of amino acid region 659-663 of Factor Va heavy chain to the activity of factor Xa within prothrombinase .

Jamila Hirbawi, John L Vaughn, Michael A Bukys, Hans L Vos, Michael Kalafatis

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Cryo-EM structures of coagulation factors.Research and practice in thrombosis and haemostasis · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Jamila HirbawiDepartment of Chemistry, Cleveland State University, Cleveland, Ohio 44115, USA.
John L Vaughn
Michael A Bukys
Hans L Vos
Michael Kalafatis
Cleveland State University · USCleveland Clinic · USLeiden University Medical Center · NL

Funding

TRAINING PROGRAM IN VASCULAR CELL BIOLOGYT32HL007914 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI PLOW, EDWARD FRANKLIN · 1999 to 2011
$2.2M
Functional Domains of Coagulation Factor VR01HL073343 · NHLBI · CLEVELAND STATE UNIVERSITY · PI KALAFATIS, MICHAEL · 2004 to 2007
$1.1M
Factor Va regulation of prothrombinase activityF31HL085928 · NHLBI · CLEVELAND STATE UNIVERSITY · PI HIRBAWI, JAMILA · 2006 to 2010
$126k
NHLBI NIH HHS F31 HL-085928NHLBI NIH HHS R01 HL-73343NHLBI NIH HHS T32 HL 007914
6 · The paper itself

Abstract

Factor Va, the cofactor of prothrombinase, is composed of heavy and light chains associated noncovalently in the presence of divalent metal ions. The COOH-terminal region of the heavy chain contains acidic amino acid clusters that are important for cofactor activity. In this work, we have investigated the role of amino acid region 659-663, which contains five consecutive acidic amino acid residues, by site-directed mutagenesis. We have generated factor V molecules in which all residues were mutated to either lysine (factor V(5K)) or alanine (factor V(5A)). We have also constructed a mutant molecule with this region deleted (factor V(Δ659-663)). The recombinant molecules along with wild-type factor V (factor V(WT)) were transiently expressed in mammalian cells, purified, and assessed for cofactor activity. Two-stage clotting assays revealed that the mutant molecules had reduced clotting activities compared to that of factor Va(WT). Kinetic analyses of prothrombinase assembled with the mutant molecules demonstrated diminished k(cat) values, while the affinity of all mutant molecules for factor Xa was similar to that for factor Va(WT). Gel electrophoresis analyses of plasma-derived and recombinant mutant prothrombin activation demonstrated delayed cleavage of prothrombin at both Arg(320) and Arg(271) by prothrombinase assembled with the mutant molecules, resulting in meizothrombin lingering throughout the activation process. These results were confirmed after analysis of the cleavage of FPR-meizothrombin. Our findings provide new insights into the structural contribution of the acidic COOH-terminal region of factor Va heavy chain to factor Xa activity within prothrombinase and demonstrate that amino acid region 659-663 from the heavy chain of the cofactor contributes to the regulation of the rate of cleavage of prothrombin by prothrombinase.

Indexed as

Amino Acid SequenceAnimalsEnzyme PrecursorsFactor VFactor VaFactor XaGene ExpressionHumansMolecular Sequence DataMutagenesis, Site-DirectedMutant ProteinsPoint MutationProthrombinRecombinant ProteinsSequence AlignmentThrombinEnzyme PrecursorsFactor VFactor VaFactor XameizothrombinMutant ProteinsProthrombinRecombinant ProteinsThrombinThromboplastin

Identifiers

PMID20722419
PMCPMC2946813
OpenAlexW2038586872

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.